Home
About
Overview
Sharing Data
ORCID
Help
History (102)
STAT5 is required for thymopoiesis in a development stage-specific manner.
Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine.
APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations.
Mechanisms of hemorrhage in dengue without circulatory collapse.
Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
See All 102 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
Lee MM. Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents? N Engl J Med. 2003 Mar 06; 348(10):942-5.
View in:
PubMed
subject areas
Adolescent
Body Height
Bone Density
Child
Enzyme Inhibitors
Gonadotropin-Releasing Hormone
Growth Disorders
Humans
Puberty
Triptorelin Pamoate
authors with profiles
Mary M Lee MD